Compounds > 1,2-bis(3,5-dioxopiperazin-1-yl)ethane
Page last updated: 2024-08-25

1,2-bis(3,5-dioxopiperazin-1-yl)ethane and edetic acid

1,2-bis(3,5-dioxopiperazin-1-yl)ethane has been researched along with edetic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jirkovská, A; Karabanovich, G; Piskáčková, HB; Reimerová, P; Roh, J; Šimůnek, T; Štěrbová-Kovaříková, P1

Other Studies

1 other study(ies) available for 1,2-bis(3,5-dioxopiperazin-1-yl)ethane and edetic acid

ArticleYear
UHPLC-MS/MS method for analysis of sobuzoxane, its active form ICRF-154 and metabolite EDTA-diamide and its application to bioactivation study.
    Scientific reports, 2019, 03-14, Volume: 9, Issue:1

    Topics: Animals; Antineoplastic Agents; Cells, Cultured; Chromatography, High Pressure Liquid; Edetic Acid; Myocytes, Cardiac; Piperazines; Rats; Rats, Wistar; Razoxane; Tandem Mass Spectrometry

2019